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Abstract: Mycobacterium avium subspecies paratuberculosis (Map) causes Johne’s 
disease in animals and is significantly associated with Crohn’s disease (CD) in humans. 
Our previous studies have shown Map to be present in U.K. rivers due to land deposition 
from chronic livestock infection and runoff driven by rainfall. The epidemiology of CD in 
Cardiff showed a significant association with the River Taff, in which Map can be detected 
on a regular basis. We have previously hypothesized that aerosols from the river might 
influence the epidemiology of CD. In this preliminary study, we detected Map by 
quantitative PCR in one of five aerosol samples collected above the River Taff. In addition, 
we examined domestic showers from different regions in the U.K. and detected Map in 
three out of 30 independent samples. In detecting Map in river aerosols and those from 
domestic showers, this is the first study to provide evidence that aerosols are an exposure 
route for Map to humans and may play a role in the epidemiology of CD. 
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1. Introduction 
Mycobacterium avium subspecies paratuberculosis (Map) is a member of the Mycobacterium 
avium complex [1,2]. It has the specific ability to cause chronic inflammation of the intestine, or 
Johne’s disease (JD) [3–5], which can affect many animal species, including primates [6,7]. This 
enteric pathogen is significantly associated with chronic inflammation of the intestine of the Crohn’s 
disease (CD) type in humans [8–10]. 
Subclinical infection is widespread in domestic livestock, especially cattle, sheep and goats [3]. 
Infection and disease has now spread worldwide [11,12], with Europe and North America being 
particularly affected [3,13]. It is estimated that the herd prevalence for JD in cattle in the USA is 68% [14] 
and 32% in U.K. [3,15,16]. Both clinically and sub-clinically infected animals can shed Map  
in variable numbers on to pasture in their faeces, depending on the animal, the pathogen strain and the 
disease characteristics [6]. The organism can survive for many months in agricultural slurry and in the 
wider environment [17–20]. 
Rain falling onto pastures contaminated with Map washes it into surface waters and into  
rivers [19,20]. Previously, we showed that Map was present in 32% of samples taken from the River 
Taff (Cardiff, South Wales, UK) and its presence was almost predictable from rain fall patterns and 
river flow [19], whereas its frequency in samples from the River Tywi was 69% and its presence 
predictable [20]. Furthermore, deposition and transport from the catchment was extensive in that Map 
was maintained in the river for several weeks at a time and was a consequence of the endemic presence 
of Map in cattle in the Taff catchment [19]. Pickup and co-workers [20] modelled the main human 
exposure routes of Map and suggested that although driven by shedding from clinically and sub-clinically 
infected animals, the presence and distribution of Map in the environment may also be influenced by 
other factors, such as slurrying and soil redistribution from water treatment that recycles Map back 
from the catchment to the river [19,20]. Water from rivers or reservoirs is used for abstraction and 
public supply. Inevitably Map has been detected in the drinking water supply systems [20–26]. 
Furthermore, mycobacteria, including M. avium subspecies avium, have been found in  
domestic showers [27–29]. 
Cardiff has one of the highest incidences of CD in the U.K., with a corrected incidence for the 
decade (1996–2005) of 6.6 per 105 population per year (with a 95% confidence interval of 58–76) with 
a concomitant increase in incidence in children under 16 [30,31]. This compares with 5.6 per 105 
population per year (with a 95% confidence interval of 44–68) for the period 1991–1995 [32], 
5.9/105/year for 1986–1990 [33] and 5.0/105/year over the period from 1976 to 1980 [34]. The 
epidemiological study carried out by Mayberry and Hitchens in the late 1970s [35] examined the 
incidence and geographical distribution of Crohn’s disease and ulcerative colitis in 25 electoral wards 
in the city of Cardiff. They found a statistically highly significant (p < 0.001) increase in the incidence 
of Crohn’s disease, but not of ulcerative colitis, in 11 of the city wards. Although eight of these  
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high-incidence wards bordered the River Taff, their apparent geographical relationship with the river 
was not statistically significant [35,36]. Figure 1B shows the city of Cardiff with an indication of the 
direction of the prevailing south westerly winds [19]. The distribution of the wards with a high 
incidence of Crohn’s disease throughout the city is shown in Figure 1B [19]. The topography of the 
approaches to the southwest aspect of the river is characterized by hills to the north and south. The 
valley in between, open to the prevailing winds, is directly opposite the gap in the centre of the  
high-incidence wards on the windward bank of the river. On the leeward side, three additional  
high-incidence wards lie immediately adjacent to those bordering the river to the northeast. Previously, 
we suggested that this is the direction in which aerosols containing Map would be carried on the 
prevailing south westerly winds and proposed that, through aerosolisation of Map, this exposure route 
is an explanation for the observed disease clusters around the River Taff [19]. 
Figure 1. Relationship between disease clusters and prevailing wind in Cardiff, Wales, 
United Kingdom. (A) Location of the city of Cardiff within the UK (red dot); (B) 
distribution of the 11 electoral wards (shown with black boundaries) in the city of Cardiff 
that were shown previously (53, 54) to have a highly significant (p < 0.001) increase in the 
incidence of Crohn’s disease. The wards with the high incidence of Crohn’s disease are 
seen to lie along the River Taff (blue), which flows into the Bristol Channel (blue), with 
the exception of a gap in the centre stretch of the windward right bank of the river (facing 
downstream). This gap directly faces a valley between hills to the north and south, which is 
open to the prevailing southwesterly winds (black arrow; with permission from [19]). The 
dashed line represents the continuation of the coast. The white bar represents 3 km. The red 
dot represents the sampling site.  
 
In the present study, we tested whether we could detect Map in aerosols originating from the River 
Taff, using a high volume impaction sampler (HVIS) designed for collecting particulate matter  
(PM 2.5–10; Figure 2) [35–37]. We also investigated domestic showers to find out whether they could 
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be a source of exposure; thus seeking to extend the diverse routes for human exposure proposed by  
Pickup et al. [20]. 
Figure 2. Aerosol sampling using a high volume impaction system. (A) The system in 
place connected to a high volume vacuum pump (not shown); (B) the sampler showing the 
position of the four foam collection substrates; (C) the foam placed in position over one of 
the slit nozzle cascade impactors (see arrow); (D) the foam removed from the slit nozzle 
cascade impactors (ii) showing collected particles from the sampler (i). 
 
2. Results 
2.1. Aerosols 
2.1.1. The Efficiency of Recovery of Bacteria from the Foam Collection Substrate 
This is the first study to make use of the HVIS for microbiological analysis. The foam collection 
substrate, originally designed for particulate matter (PM10) capture, was tested for ease of recovering 
culturable bacteria, as it was anticipated that there would be some cell loss due to adsorption and 
derived from the clumping associated with mycobacteria. In separate experiments, foams were infused 
with E. coli JM101 and M. immunogenum over a serial dilution range delivering cell numbers from  
10–107 CFU mL−1 for E. coli and 10–105 CFU mL−1 for M. immunogenum. For E. coli, the efficiency 
of recovery decreased with decreasing infusion concentration from approximately 200% (for  
106/107 CFU mL−1 infusions, possibly due to cell multiplication at high cell density) to 69%–43% for 
an infused cell concentration in the range of 10–105, respectively. No CFU were recovered when the 
foam was seeded with 10 CFU mL−1. M. immunogenum was infused in the range 10–105 CFU mL−1 
with CFU only being recovered from the 105 cell infusion at an efficiency of 0.05%. The detection of  
M. immunogenum by qPCR demonstrated variable recoveries of between 0.08% and 3.05% for the cell 
equivalent (CE) infusion range 10–107, respectively, indicating better recovery at low cell density. No 
CE were detected by qPCR when initially infused below concentrations of 101 CE mL−1. Overall 
Pathogens 2014, 3 581 
 
 
results indicated that bacteria could be recovered from the foam collection substrate, originally 
designed for PM10 collection, but the efficiency of recovery is likely dependent on the concentration 
and cell type. 
2.1.2. Analysis of River Taff Foam Collection Substrates 
2.1.2.1. Culture 
River aerosols were obtained on five occasions, with each filtering a total of 198 m3 of air per 
sampling session. Both heterotrophic plate counts and direct microscope counts were carried out on the 
bacteria recovered from the foam collection substrates located at the top, middle and bottom of the 
HVIS (Table 1; Figure 2). 
Table 1. Assessment of the bacterial load of aerosols from the River Taff by epifluorescence 
microscopy and the culture of general heterotrophic bacteria. (Samples were collected 
between November, 2010, and September, 2011; ND, not determined). 
Date 
(MM/DD/YY) 
Filter Level 
Culturable Counts (R2A Agar) 
Mean CFUs m−3  
(Standard Deviation) 
Direct Counts (DAPI) 
Mean Cells m−3 
 (Standard Deviation) 
11.09.10 
Top 1.11 × 104 (±3.21 × 103) 1.89 × 105 (±9.62 × 104) 
Upper Middle 6.01 × 104 (±1.17 × 104) 1.60 × 105 (±6.27 × 104) 
Lower Middle ND ND 
Bottom 1.19 × 102 (±1.06 × 102) ND 
05.24.11 
Top 1.58 × 104 (±8.17 × 1032) 2.58 × 105 (±1.47 × 105) 
Middle ND ND 
Bottom ND ND 
06.15.11 
Top 5.65 × 104 (±2.56 × 104) ND 
Middle ND ND 
Bottom ND ND 
08.17.11 
Top 5.86 × 104 (±4.23 × 103) 5.20 × 107 (±2.46 × 107) 
Upper middle 1.27 × 105 (±2.45 × 104) ND 
Lower middle 2.12 × 102 (±9.68 × 101) ND 
Bottom  0 ND 
09.21.11 
Top 3.50 × 104 (±2.19 × 104) 2.75 × 105 (±1.64 × 105) 
Upper middle 2.26 × 103 (±1.73 × 102) 3.91 × 104 (±1.16 × 104) 
Lower middle 3.90 × 101 (±5.08 × 10°) ND 
Bottom 0 ND 
The foams collected bacteria in decreasing numbers from “top” to “bottom” in the mean range  
6.01 × 104 to 3.90 × 101 CFU m−3 for culturable bacteria and in the mean range 5.2 × 107 to  
3.91 × 104 CFU m−3 for direct counts. There was no significant difference between the culturable 
numbers collected on the top and upper middle foams (mean 4.7 × 105 ± 7.2 × 105 CFU m−3), but the 
difference in numbers between the top and lower middle and bottom were close to being significantly 
different (p = 0.06). Direct counts by microscopy for top and upper middle foams had a mean  
8.8 × 107 ± 2.1 × 108 cells m3, with no significant difference between top and upper middle foams. 
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Therefore, the HVIS collected the majority of bacteria from the air passing over the river in the top and 
upper middle collection substrates. 
2.1.2.2. Molecular Analyses 
16S rrn gene amplification was successful from all top and upper middle section foams throughout 
the sampling period. The bottom sections were all negative. PCR detection was not observed in 
samples where general heterotrophs numbered <103 CFU m−3 (Table 2). 
Table 2. PCR detection of eubacteria (16S rrn gene) Mycobacterium spp. (gMyc) and Map 
(IS900 and F57) in aerosol collection foams collected from November, 2010, to 
September, 2011 (CE, cell equivalents). 
Date 
(MM/DD/YY) 
Filter Level 
Eubacterial 
16S rrn Gene 
Mycobacterium spp. 
16-23S rRNA ITS 
(gMyc) (CE m−3) 
Map IS900 
(CE m−3) 
Map F57 
(CE m−3) 
11.09.10 
Top + 0 0 0 
Upper Middle + 0 1–10 0 
Lower middle - 0 0 0 
Bottom - 0 0 0 
05.24.11 Top + 0 0 0 
06.15.11 Top + 0 0 0 
08.17.11 
Top + 1–10 0 0 
Upper middle + 0 0 0 
Lower middle - 0 0 0 
Bottom - 0 0 0 
09.21.11 
Top + 0 0 0 
Upper middle + 0 0 0 
Lower middle - 0 0 0 
Bottom - 0 0 0 
Mycobacterial spp. were detected using the gMyc genus-specific assay in the foam on one occasion 
(08.17.11; Table 2). Map was detected by PCR (IS900 only) on a different occasion (11.09.10) and 
was found in the upper middle filter. Map was not detected by the confirmatory, but less sensitive, F57 
PCR on any occasion. In summary, bacteria were detected on collection foams by culture and direct 
counts; the extracted DNA was of sufficient quality for PCR, and Map was detected in one sample by 
IS900 PCR. 
2.2. Showers 
Samples from the biofilms in showers tubes and heads were obtained from 23 homes across four 
counties in the U.K. ((Cumbria, Lancashire, Merseyside and West Sussex; 30 samples in total); Table 3). 
  
Pathogens 2014, 3 583 
 
 
Table 3. Detection of Mycobacterium spp. and Mycobacterium avium subspecies 
paratuberculosis in shower heads and tubes by culture and qPCR (ND, not determined;  
H represents a shower head being sampled from the same shower unit; a, b represent 
different showers from the same house; and numbers represent different locations). MGIT, 
mycobacterial growth indicator tubes. 
Sample 
Location/Number 
Microscopy and Culture qPCR 
Direct Counts and 
Standard Deviation.  
(Cells L−1) 
Mycobacterial 
Culture (MGIT) 
Mycobacterium 
spp. (CE L−1) 
Map IS900 
(CE L−1) 
Map F57 
(CE L−1) 
Cumbria-1 ND ND 104–105 0 0 
Cumbria-2H ND - 106–107 0 0 
Cumbria-2 ND - 106–107 0 0 
Cumbria-3 ND - 103–104 0 0 
Cumbria-4 ND - 102–103 0 0 
Cumbria-5 ND ND 0 0 0 
Cumbria-6 ND ND 0 0 0 
Lancashire-1 ND ND 103–104 0 0 
Lancashire-2 ND ND 107–108 1–10 0 
Lancashire-3 ND - 107–108 0 0 
Lancashire-4 7.95 × 108 (±4.02 × 108) - 105–106 0 0 
Lancashire-5 ND - 106–107 0 0 
Lancashire-6 ND ND 108–109 0 0 
Lancashire-7 ND + 106–107 0 0 
Lancashire-8 ND - 103–104 0 0 
Lancashire-9 1.91 × 109 (±6.07 × 108) - 106–107 0 0 
Lancashire-10 1.63 × 109 (±5.05 × 108) + 107–108 0 0 
Merseyside -1 ND - 108–109 103–104 101–102 
Merseyside-2 ND - 107–108 102–103 102–103 
Merseyside-3 ND - 107–108 0 0 
West Sussex-1aH ND ND 107–108 0 0 
West Sussex-1a ND ND 106–107 0 0 
West Sussex-1bH ND - 106–107 0 0 
West Sussex-1b ND + 107–108 0 0 
West Sussex-2a 1.64 × 109 (±7.39 × 108) - 109–101° 0 0 
West Sussex-2b 2.25 × 109 (±1.02 × 109) - 104–105 0 0 
West Sussex-3aH ND - 104–105 0 0 
West Sussex-3a ND - 105–106 0 0 
West Sussex-3b ND + 105–106 0 0 
West Sussex-4H ND - 104–105 0 0 
Mycobacterium spp. were detected by qPCR in 28 (93%) samples covering all geographical 
regions. Their numbers ranged from 102 CE L−1 to 109–1010 CE L−1 with >20 samples containing more 
than 102–103 CE L−1 mycobacteria. The presence of viable mycobacteria was also confirmed by 
culture (with confirmation of acid-fastness by Kinyoun staining) in four out of six samples tested 
(Table 3). Map was detected in three samples from Merseyside and Lancashire, two samples of which 
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were also positive in a confirmatory F57 PCR. Furthermore, Map was only detected in samples 
carrying the higher 107–108 general mycobacterial load (Table 3). 
2.3. Discussion 
This study employed culture and higher sensitivity qPCR assays to assess two routes of human 
exposure to Map via aerosols, as proposed by Pickup et al. [19,20], namely, those from rivers and 
domestic showers. 
2.3.1. River Aerosols 
Various types of collection devices are available, such as impingers with a low volume collection of 
10–30 L min−1, although some have a capacity of approximately 1000 L min−1 [38,39]. Both dry and 
liquid collection systems have limitations, such as short collection times, impaction problems and low 
volume collection [38,40]. Our river sampling strategy for aerosols employed a high volume impaction 
system (HVIS; commonly referred to as the Cardiff Super-Sucker), which is normally used to study 
PM10 in urban and rural areas [37]. To our knowledge, there is no dedicated apparatus to facilitate the 
specific detection of aerosolized bacteria in such large volumes. As such, it was necessary to show the 
applicability of the HVIS system to the capture and recovery of bacteria in the present study. We 
demonstrated the use of the apparatus and showed that viable bacteria can be recovered from  
River Taff aerosols by culturing bacteria from 198 m3 air samples collected on each deployment. This 
recovery occurred despite the harsh physical and physiological conditions that the unit imposes on the 
bacteria and the non-standard collection foams used. The HVIS was placed near a weir, where the 
physical disturbance of the river would probably increase our chances of collecting aerosols. 
Map was detected by IS900 qPCR, on one out of five sampling occasions, albeit in the range of  
1–10 CE m3, but not by the less sensitive F57 PCR, which is consistent with the estimated Map 
numbers detected. In a previous qualitative study (presence/absence PCR; [19]), Pickup et al. (2005) 
sampled the river Taff waters for one year and reported that 32% of river samples at a location 1 km 
upstream from the present site were positive for Map [19]. The 2005 study [19] was the result of a 
feasibility study comprising seven ad hoc sampling sessions, previously spread out over several 
months. Map was detected in only one of those seven samples. However, its detection led to the more 
intensive sampling regime that was later reported [19]. We subsequently showed that the ad hoc 
feasibly study returned a low Map-positive rate because the bacterium is transported in the river in 
pulses driven by rainfall and that there are periods where Map is not detected [19,20], and we sampled 
on all, but one, of those occasions. The conclusions of the present study mirror that of our previous 
studies [19,20,41] in that sampling and detection methods likely underestimate actual Map numbers. 
More specifically, previous experience from ad hoc sampling and Map screening followed by more 
intense and frequent assessments in 2005 suggest that if we were able to collect aerosol samples on a 
twice weekly basis at the present sampling site, then our model for the River Taff would suggest a 
higher detection of Map in aerosol samples [19]. This is our intention in future studies. 
Both the ability of aerosol droplets to concentrate bacteria and the spread of mycobacteria in 
aerosols are well documented [23,42–47]. More specifically, Map has been detected in aerosols in 
cattle barns and within the farm environment [48–51] and has been identified as a possible route for 
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infection for Johne’s disease in cattle [52]. Although limited in scope and resolution, our feasibility 
study is the first to show that Map is airborne in non-farm environments, namely in aerosols emanating 
from rivers, and its presence fits the criteria in our understanding of the Map loading of rivers and its 
transportation drivers from the catchment [19]. 
This study also gives credence to our suggestion that the epidemiology of Crohn’s patients in 
Cardiff (UK) is affected by aerosols, due to the significant association with the river and the prevailing 
wind direction [19]. The study by Mayberry and Hitchens [35] examined the distribution of Crohn’s 
disease patients in Cardiff based on age, sex, religion, smoking, drinking and drug taking with no 
statistical difference within and between these parameters [35]. They found, however, that CD patients 
appeared in highly significant clusters and that these were closely associated with the course of the 
River Taff with larger concentrations of CD nearer the source mouth (Tiger Bay). Mayberry and 
Hitchens [35] suggested that environmental factors associated with the river may contribute to the 
disease distribution. We suggest that, although more study is needed, aerosols might be the missing 
factor suggested by Mayberry and Hitchens [35,36,53,54] and ourselves [19]. Taken together with our 
present results and those that show that Map is significantly associated with Crohn’s disease [8,10], 
these data suggest that the pattern of clustering of Crohn’s disease in Cardiff may have been due to the 
long-term inhalation of M. avium subsp. paratuberculosis from the River Taff. 
2.3.2. Shower Heads 
Furthermore, water is abstracted from rivers for domestic use. Given the widespread geographical 
distribution of Map [41] and its presence in water ways [19,20,24], it is not surprising that the delivery of 
domestic water supply may prove an issue. Mycobacteria have been found in drinking water [21,22,29], 
and pathogens, including mycobacteria, have been found in showerheads [27,29]. Furthermore,  
non-tuberculous mycobacteria (NTM) and other opportunistic human pathogens were enriched to high 
levels in many showerhead biofilms [27]. These authors concluded that showerheads may present a 
significant potential exposure to aerosolized microbes, including documented opportunistic pathogens. 
Our results support this with qPCR, showing 28 of 30 (93%) samples to be positive for Mycobacterium 
spp. in a range from 102–1010 CE L−1. Additionally, we report for the first time the specific detection 
Map in shower tubes in numbers from 101–104 CE L−1 with two samples confirmed as Map-positive by 
both IS900 and F57 PCR and one other unconfirmed Map-positive in which IS900 was detected solely 
(1–10 CE 1−1). The presence in the shower tube will result in frequent sloughing from the surface of 
the biofilm, resulting in the appearance of Mycobacterium spp. and Map in shower water and the 
potential for subsequent inhalation via shower-generated aerosols as suggested by Feazel et al. [27]. 
3. Experimental Section 
3.1. Bacterial Strains and Culture 
Escherichia coli strain JM101 was maintained on nutrient agar and cultured overnight at 30 °C in 
nutrient broth (Oxoid, UK) with shaking at 180 rpm. General heterotrophs were cultured at 30 °C on 
solid R2A medium (Oxoid, UK) for 48 h. Mycobacterium immunogenum ATCC 700505T was cultured 
at 30 °C for up to 1 week on Middlebrook 7H10 agar supplemented with OADC (10% v/v) and 
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glycerol (5% v/v) (BD Biosciences, Oxford, UK) or in mycobacterial growth indicator tubes (MGITs), 
supplemented with OADC (10% v/v) [54]. Mycobacterium avium subsp. paratuberculosis K-10 (Map) 
and general mycobacteria from shower samples were cultured in the same way, but with the addition 
of polymyxin B sulphate (100 µg mL−1), cycloheximide (25 µg mL−1) and mycobactin J (2 µg mL−1); 
and increased incubation times of up to 6 months (Map culture only). 
3.2. Sampling Sites 
Aerosol sampling took place from the east bank on the River Taff at Blackweir, Bute Park Cardiff 
(GBOS ST170780), between November, 2010, and September, 2011. Shower samples were taken from 
a number of houses across England during the period 2011–2013. 
3.3. Shower Sampling 
Domestic shower samples were obtained by removal of the shower hose from the shower unit and 
shower head and emptied of standing water. Sterile glass beads (1 g; 5 mm in diameter) in 10 mL 
sterile 1 × PBS were poured into the pipe. The ends were sealed with alcohol-washed parafilm (Bemis 
Ltd, UK), and the pipe was manually shaken for 2 min to remove the internal biofilm. The contents 
were poured into a sterile McCartney bottle, sealed and put on ice prior to transport and processing: the 
culture of mycobacteria (Section 3.3.1), direct counts by microscopy (Section 3.5) and qPCR  
(Section 3.6 and 3.7). Counts obtained from 5-mL samples were converted to cells L−1 or CE L−1. 
3.3.1. Recovery of Mycobacteria from Shower Biofilms 
For the recovery of mycobacteria from shower samples, 5 mL of the sample obtained above was 
centrifuged for 30 min at 4000× g. Samples were then decontaminated to favour the growth of robust 
mycobacteria, whilst eradicating other bacteria and fungi. Concentrated shower samples were  
re-suspended in 1 mL 0.7% hexadecylpyridinium chloride and incubated at room temperature for 1 h. 
This was followed by centrifugation for 30 min at 4000× g and re-suspension in 500 µL sterile PBS. 
Two hundred microlitres of this sample were then inoculated into MGITs and 100 µL onto 7H10 solid 
medium in triplicate, as described above. Mycobacterial growth either as colonies on solid media or 
from clumped cells in MGITs was confirmed by checking for both acid fastness by Kinyoun staining 
(as per the manufacturer’s instructions; Becton Dickinson Diagnostics, Oxford, UK) and DNA extraction 
followed by quantitative real-time PCR (qPCR) using the Mycobacterium genus-specific assay 
described below. 
3.4. Aerosol Sampling 
3.4.1. Collection 
Aerosol collection was carried out using a high-volume (low cut-off; 1100-1/min) impaction system 
(HVIS; Figure 2) linked to a 240 V voltage high performance vacuum pump [37,55]. The HVIS 
comprised a series of multistage round slit nozzle cascade impactors, which direct incoming air 
through four sterile polyurethane foam collection substrates labelled by position within the unit (top, 
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upper and lower middle and bottom) [56,57] (Figure 2a,b). The HVIS was configured to collect 
particles in the ranges 10–2.5 µm and 2.5–0.1 µm, with the size being determined by the slit nozzles 
rather than the collection substrate [56] (Figure 2b). The HVIS was run for 3 h on the opposite river 
bank to the prevailing wind. Upon return to the laboratory, the multistage impactors were disassembled 
aseptically in a microbiological safety cabinet (Figure 2c), the circular foam collection substrates 
removed, cut into quarters using sterile scissors and placed at −80 °C in sterile plastic 50-mL 
centrifuge tubes (Figure 2d) until required. Each of the collection foams was processed separately. 
They were then aseptically transferred to stomacher bags and 20 mL sterile 1× PBS and placed in the 
stomacher (Stomacher® 80 Biomaster; Seward Ltd., Worthing, UK). Stomaching was performed at the 
“high speed” setting (300 rpm ±5%) for 5 min at room temperature. The total volume of this 
suspension was then decanted into sterile 50 mL tubes and cells concentrated to 1 mL by 
centrifugation 16,000× g for 10 min at room temperature. This final suspension was then used for 
culture and DNA extraction for qPCR estimates of cell numbers of mycobacteria and MAP. 
3.4.2. Controlled Assessment of the Efficiency of Cell Recovery from Foam Substrates 
To test the efficiency of recovery of cells foam substrates used in the HVIS aerosol collector, 
substrates were infused with E. coli JM101 (to give a representative sample of a fast growing general 
heterotrophy) and with M. immunogenum (a fast growing non-tuberculous mycobacterium, which 
aggregates into cell clumps, typical of mycobacteria). Foam substrates were cut into 1-cm strips and 
sterilised by autoclaving prior to use. Sterile foams were then placed into sterile 1.5-mL Eppendorf 
tubes and infused with 100 µL of cell suspension. This volume had previously been shown to be fully 
retained by the foam (not shown). Cultures of E. coli JM101 and M. immunogenum were grown to 
approximate cell concentrations of 108 mL−1 before centrifugation for 3 minutes at 3000× g and  
re-suspension in sterile 1 ×PBS. Separate cell suspensions of each culture were serially diluted to 10−7 
in 1× PBS to provide an estimate of how the efficiency of recovery changed across a range of 
concentrations. Infused foams were undisturbed for 1 h at room temperature. They were then 
aseptically transferred to stomacher bags and processed as described previously. The final suspension 
was then used for culture and DNA extraction for qPCR estimates of cell numbers. E. coli and  
M. immunogenum were cultured as above, and the efficiency of cell recovery was determined by 
comparing the colony forming units CFU mL−1 (or cell equivalents, see below) recovered to that of the 
original cultures used for infusion. Due to cell clumping that affects mycobacterial CFU counts,  
M. immunogenum cell equivalents [55] were also assessed by qPCR, as described below. 
3.5. Direct Microscope Counts 
Direct counts were carried out using DAPI staining [58] using a Leitz labarlux S epifluorescence 
microscope at ×1250 magnification under UV excitation at 358 nm and emission at 430 nm. 
3.6. DNA Extraction 
Total nucleic acids were extracted from all samples using the MagMax total nucleic acid extraction 
kit (P/N AM1840, Life Technologies, Paisley, UK) according to manufacturer’s instructions, apart 
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from replacement of kit-supplied carrier nucleic acid with molecular reagent water (Sigma Aldrich 
Ltd., Poole, UK). Cell lysis by bead beating was performed on a FastPrep®-24 instrument (MP 
Biomedicals, Loughborough, UK) for 2 cycles of 1 min at a speed of 6.5 m/s (with 5 min at room 
temperature in between cycles). All samples were processed in sterile 1.5-mL microcentrifuge tubes. 
Nucleic acid extractions were also performed with 200 μL of PCR water (Sigma Aldrich Ltd., Poole, 
UK) as a negative control. DNA quality and concentration were determined using a Nanodrop 8000 
spectrophotometer (Labtech International Ltd., Ukfield, UK). Finally, all total nucleic acids were 
stored at −80 °C. 
3.7. PCR Amplification and qPCR 
End-point PCR amplification was carried out using a Veriti thermal cycler (P/N 4375786,  
Life Technologies) in MicroAmp 96-well thin-walled reaction plates (P/N 4346906, Life Technologies). 
Amplification of the 16S rrn gene was carried out using primers pE and pH’ [59]; Table 4). Reactions 
(20 µL) were performed using and in strict accordance with the instructions provided with the 
AmpliTaq Gold 360 Master Mix system (P/N 4398881, Life Technologies). 
Table 4. PCR primers and hydrolysis probes used in this study. * Our designation as 
oligonucleotides were originally simply the forward and reverse primer Taqman probe 
when described in van Coppenraet et al. (2004). 
Oligonucleotide Sequence and Fluorophore/Quencher (5'→3') Target Gene Reference 
pE (forward) AAACTCAAAGGAATTGACGG Eubacterial 16S rrn gene 
[59] 
pH’ (reverse) AAGGAGGTGATCCAGCCGCA Eubacterial 16S rrn gene 
MimmFP (forward) TTGATGTGCAGACGGATTCC M. immunogenum rpoB 
[55] 
MimmRP (reverse) CAACCTCGCGCCAACG M. immunogenum rpoB 
MimmTP 
(hydrolysis probe) 
VIC-TTGAATGGTTGGTCGGCTCGCC-
TAMRA 
M. immunogenum rpoB 
gMycFP *  
(forward) 
GGGGTGTGGTGTTTGAG 
Mycobacterium genus 16S-23S 
rrn gene ITS 
[60] 
gMycRP *  
(reverse) 
CTCCCACGTCCTTCATC 
Mycobacterium genus 16S-23S 
rrn gene ITS 
gMycP *  
(hydrolysis probe) 
6FAM-TGGATAGTGGTTGCGAGCATC-
TAMRA 
Mycobacterium genus 16S-23S 
rrn gene ITS 
IS900qPCRF 
(forward) 
GATGGCCGAAGGAGATTG 
M. avium subsp. 
paratuberculosis IS900 
[61] 
IS900qPCRR 
(reverse) 
CACAACCACCTCCGTAACC 
M. avium subsp. 
paratuberculosis IS900 
IS900qPCRTM  
(hydrolysis probe) 
6FAM–
ATTGGATCGCTGTGTAAGGACACGT–BHQ 
M. avium subsp. 
paratuberculosis IS900 
F57-F (forward) TACGAGCACGCAGGCATTC 
M. avium subsp. 
paratuberculosis F57 
[62] F57-R (reverse) CGGTCCAGTTCGCTGTCAT 
M. avium subsp. 
paratuberculosis F57 
F57 Taqmanmgb  
(hydrolysis probe) 
VIC-CCTGACCACCCTTC-MGB 
M. avium subsp. 
paratuberculosis F57 
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Where practicable, all real-time quantitative PCR amplifications were performed and reported in 
accordance with the MIQE guidelines [62]. Amplifications were carried out in a 7500 FAST  
Real-Time PCR system (Life Technologies, Paisley, UK) in MicroAmp optical reaction plates  
(P/N N801–0560, Life Technologies). Primers and hydrolysis probes specific to each of 
Mycobacterium immunogenum, Mycobacterium spp. and Map are listed in Supplementary Table 1. 
Map was detected by qPCR using single-tube duplex reactions that combined the previously 
described assays [61,62] to amplify Map-specific regions IS900 and F57, respectively. These assays 
comprised primers and hydrolysis probes described in Supplementary Table 1. Primer and probe 
concentrations were optimized such that each reaction (20 µL) contained the following: 10 µL of  
2 × Environmental Master Mix (P/N 4396838, Life Technologies, UK); 1 µL (300 nM) of each primer 
(P/N 4304972, Life Technologies, UK) and 1 µL (250 nM) of each probe (P/N 450003, Life 
Technologies, UK); 2 µL of sterile PCR grade water (Sigma-Aldrich, UK); and 2 µL DNA.  
No template controls received sterilized PCR-grade water instead of DNA. The following cycling 
profile was used: one cycle of 95 °C for 10 min (for the activation of the AmpliTaq Gold enzyme) and  
45 cycles of 95 °C for 15 s and 60 °C for 1 min. DNA used in standard curves was quantified and 
standard curves constructed in accordance with methods outlined in Rhodes et al., (2008), based upon 
a genome size of 4.83 Mbp for M. avium ssp. paratuberculosis K-10 (GenBank Accession  
No. NC002944) and an average number of gene copies per genome of 17 (IS900) and 1 (F57) [63,64]. 
The sensitivity of the IS900 and F57 assays was determined for the present study using serially-diluted 
Map K-10 DNA. The limit of detection of the combined duplex assay of IS900 and F57 was 20–50 cell 
equivalents (CE; see [55]). All reactions were carried out in triplicate. Inhibition of the PCR reaction 
was tested in a separate round of reactions after the initial MAP assessments by the addition of 2 ng of 
Map K-10 DNA (approximately 4 × 105 genomes) to all samples and to control reactions where no 
sample DNA was added. No amplification, or a shift to a higher quantification cycle (Cq) value [65] 
when compared with the control reactions, was interpreted as inhibition. 
4. Conclusions 
Both river aerosol and shower unit results presented here are consistent with inhalation as a 
probable exposure route of M. avium subsp. paratuberculosis and other non-Map mycobacterial 
infections. Inhalation has been shown as a route for the infection of cattle [49,66]. M. avium subsp. 
avium demonstrates selective binding to pulmonary surfactant proteins [67]. Lung involvement is well 
described in adults with Crohn’s disease [67,68], and the disease in children often begins with a cough 
and a mild granulomatous tracheobronchitis [69–73]. Initial invasion via the oral route followed by 
Map’s substantial tissue tropism for the gut may result in chronic inflammation of the intestine [74,75]. 
Although Map is difficult to detect and even more difficult to culture, recent data has shown it to be 
significantly associated with Crohn’s disease and, if appropriate culture and PCR tests are done 
correctly, that almost everyone with chronic inflammation of the gut of the Crohn’s disease type is 
found to be infected with this chronic enteric pathogen [8,10,76–80]. Delivery of Map from showers 
and river aerosols may provide two previously undescribed human exposure routes for the pathogen 
significantly associated with Crohn’s disease. 
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